BioAssay Works

BioAssay Works® is focused on antibody-based and antigen-based detection technologies, and on their application in lateral-flow immunoassay for both instrumented and visually-read tests. The company holds substantial trade-secret-protected intellectual property, especially in production of unique, high-sensitivity, concentrated gold sols and gold conjugates. The company holds a patent for its C-FLAT® lateral-flow test platform.

The founders of BioAssay Works® are leaders in the immunoassay field and in related technologies. The company has become the assay-development partner of choice for many established players in the rapid-assay industry. Based on the demonstrable superiority of tests developed by BioAssay Works, the company's scientists have earned a world-class reputation.

BioAssay Works brings laboratory-based, ELISA-like sensitivity to rapid-format, lateral-flow assays, while maintaining field-use product durability and simplicity. The combination of proprietary nanoparticle technology, patented assay platform and extensive assay-development experience enables the company to meet the objectives of its clients.

BioAssay Works, LLC has been awarded a grant by Maryland Technology Development Corporation (TEDCO) under its Fort Detrick Technology Transfer Initiative (FDTTI). The grant is for development of an optimized, highly sensitive, rapid, visual diagnostic test able to detect and differentiate among multiple pathogenic poxviruses, including smallpox.

Search for products by BioAssay Works

BioAssay Works products by Product Category

• 
  ELISA & Immunoassays
• 
  Instruments & Equipment
• 
  Other Assays & Kits
• 
  Reagents & Chemicals
• 
  All Products

BioAssay Works products by Research Area

• 
  Food Safety
• 
  Metabolism
• 
  Oncology